Beyond tumour-specific research, EORTC looks at every aspect of cancer therapy, including Pharmacology and Molecular Mechanisms, Pathobiology, Radiotherapy and Imaging. We have extensive experience in preclinical testing of new anticancer agents, receptors, and tumour markers, as well as in the study of quality of life and patient-reported outcomes.
